With respect to Alzheimer’s disease, recent results (55) have identified an insulin-degrading enzyme as playing a critical role in removing both excess insulin and amyloid β-protein from the brain. This evidence concerns the gene INS and early-onset autosomal dominant Alzheimer disease.